Contact
Please use this form to send email to PR contact of this press release:
MIST NEWS: ROSEN, A LEADING LAW FIRM, Encourages Milestone Pharmaceuticals Inc. Investors to Inquire About Securities Class Action Investigation – MIST
TO: